Fronteo

2158.TTSE GROWTHServices

Filed as FRONTEO, Inc. (2022-06–2026-06)

Key numbers · FY ended 2026-03

Revenue¥7.6bn+25.3% YoY Operating income¥739m+40.1% YoY Net income (owners)¥544m-2.0% YoY Total assets¥9.2bn+42.3% YoY EPS (basic)¥13.86-1.7% YoY

Full financial history and reports →

Stock price2158 · View chart ↗

Open the price chart on TradingView.

Latest filings

Thu, Mar 19 · JST2 filings

13:415% STAKEFronteo · CAPSTAN MEDICAL CO., LTD. · 5.92% → 0.00%−5.92pp 12:435% STAKEFronteo · MORIMOTO MASAHIRO · 10.25% → 16.16%+5.91pp

Wed, Feb 25 · JST1 filing

17:125% STAKEFronteo · CAPSTAN MEDICAL CO., LTD. · 6.99% → 5.92%−1.07pp

Thu, Apr 24 · JST1 filing

16:00MATERIALFronteo · FRONTEO, Inc. files extraordinary report

Fri, Feb 14 · JST1 filing

16:00MATERIALFronteo · Event with a material impact on financial position

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
MORIMOTO MASAHIRO	16.16%	+5.91pp	2026-03-19

Each holder's own ratio from its most recent large-shareholding report.